Bleomycin, an antitumor antibiotic. Clinical experience in 274 patients.
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D002490:Central Nervous System / Q000187:drug effects; D004064:Digestive System / Q000187:drug effects; D006413:Hematopoietic System / Q000187:drug effects; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008168:Lung / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D010610:Pharyngeal Neoplasms / Q000188:drug therapy; D011653:Pulmonary Diffusing Capacity / Q000187:drug effects; D011658:Pulmonary Fibrosis / Q000139:chemically induced; D012129:Respiratory Function Tests; D012137:Respiratory System / Q000187:drug effects; D013997:Time Factors
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin